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Abstract
Background: Neuro-inflammatory circuits in the tissue regulate the
complex pathophysiology of pain. Protective nociceptive pain serves as an
early warning system against noxious environmental stimuli.
Tissue-resident mast cells orchestrate the increased thermal sensitivity
following injection of basic secretagogue compound 48/80 in the hind paw
tissues of ND4 mice. Here we investigated the effects of pre-treatment with
TNF-α neutralizing antibody on compound 48/80-provoked thermal
hyperalgesia.
Methods: We treated ND4 Swiss male mice with intravenous anti-TNF-α
antibody or vehicle 30 minutes prior to bilateral, intra-plantar compound
48/80 administration and measured changes in the timing of hind paw
withdrawal observed subsequent to mice being placed on a 51oC hotplate.
We also assessed changes in tissue swelling, TNF-α gene expression and
protein abundance, mast cell degranulation, and neutrophil influx in the hind
paw tissue.
Findings: We found that TNF-α neutralization significantly blocked thermal
hyperalgesia, and reduced early tissue swelling. TNF-α neutralization had
no significant effect on mast cell degranulation or neutrophil influx into the
tissue, however. Moreover, no changes in TNF-α protein or mRNA levels
were detected within 3 hours of administration of compound 48/80.
Interpretation: The neutralizing antibodies likely target pre-formed TNF-α
including that stored in the granules of tissue-resident mast cells.
Pre-formed TNF-α, released upon degranulation, has immediate effects on
nociceptive signaling prior to the induction of neutrophil influx. These early
effects on nociceptors are abrogated by TNF-α blockade, resulting in
compromised nociceptive withdrawal responses to acute, harmful
environmental stimuli.
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      Changes from Version 1
In response to feedback from our reviewers, we have updated
our research report. We have clarified in the discussion that the
effects of TNF-α on nociceptors can be both direct and indirect i.e.
mediated through other inflammatory molecules such as
COX. We have also clarified that while we see the lack of
neutrophil blockade in the presence of TNF-α neutralizing
antibodies in a relatively small experimental group of animals,
we verify neutrophil infiltration through independent assays of
myeloperoxidase enzyme activity and histological analysis of hind
paw tissue sections.
See referee reports

Introduction
Pain is one of the cardinal components of inflammation and tissueresident immune cells are important players in the regulation
of protective nociceptive responses1. Compound 48/80 (c48/80)provoked thermal hyperalgesic responses in the hind paw tissue of
male ND4 Swiss mice are mediated by the degranulation of tissueresident mast cells2. The increased sensitivity to thermal stimulus
is dependent, in part, on neutrophil influx into the affected tissue,
and on histamine signaling; the response is completely abrogated in
mast cell-deficient mice, and is substantially reduced by blocking
neutrophil influx or treatment with histamine receptor antagonists2.
The importance of neutrophil influx in nociceptive cascades has
been shown in different rodent models3–5 and the important regulatory roles of inflammatory cytokines including IL-1β, TNF-α,
and IL-6 in pain signaling have also been demonstrated6,7. Here we
show that c48/80-induced early thermal sensitivity in ND4 Swiss
mice is markedly reduced by pre-treatment with a neutralizing antibody against TNF-α. Anti-TNF-α antibody administration does not
significantly affect levels of mast cell degranulation or neutrophil
influx into the affected tissue. We also found no increase in protein
and mRNA levels of TNF-α in the tissue within the first 3 hours following c48/80 administration suggesting that this blockade targets
pre-formed TNF-α including that stored in the granules of tissueresident mast cells. Our data suggest that pre-formed TNF-α may
act rapidly on nociceptors that are known to reside in close proximity to mast cells8 and modulate nociceptor sensitization thresholds9
and function10. TNF-α blockade therefore compromises the early,
protective nociceptive withdrawal responses that normally act to
protect tissues from further exposure to acute, injurious environmental stimuli11.

Methods
Animals
Three-six month old male ND4 Swiss mice (Harlan Laboratories,
Indianapolis, IN) were housed in Macalester College’s research
animal facility with a 12-hour light/dark cycle and free access to
food and water. A total of 73 mice were used for the experiments
shown here (21 controls; 52 experimental) to ensure that appropriate statistical analysis could be performed on data acquired from
these experiments. Macalester College’s Institutional Animal Care
and Use Committee approved all experimental procedures (Protocol B08Su1).

Drug administration
All drugs were administered using 0.9% saline (VWR, Radnor, PA)
vehicle or phosphate buffered saline (EMD Millipore, Billerica,
MA). Mice received bilateral intra-plantar (i.pl.) treatments with
c48/80 (1.5μg/paw; 10μl; (Sigma-Aldrich, St. Louis, MO)) or saline
alone as previously described2. Either 200μg/kg of anti-TNF-α neutralizing antibody (R&D Systems, Minneapolis, MN, Polyclonal
Goat IgG, Catalog #: AB-410-NA) or 200μl vehicle was injected
intravenously 30 minutes prior to c48/80 injection in a protocol
adapted from Rocha et al.12. Rocha et al. administered anti-TNF-α
antibodies i.v. 5 mins prior to carrageenan treatment in a mouse
model of mechanical hyperalgesia12.
Thermal sensitivity assessment
To assess thermal sensitivity, single mice treated with i.pl. c48/80 or vehicle were placed in a Plexiglas cylinder on a hotplate analgesia meter
(Harvard Laboratories, Edenbridge, KY) maintained at 51.0 ± 0.5°C
and removed when prolonged retraction, flipping/licking of the
hind paw, or jumping with both hind paws off the hotplate were observed, but no later than 40 seconds, as previously described2. Two
baseline hotplate latencies were taken 24 and 48 hours before the
experiment. Mice with >10 second differences between baselines
or <15 second averages were excluded from the experiment. Nociceptive thermal sensitivity was quantified by subtracting the mean
baseline thermal latency from the experimental thermal latency at
each time point for each mouse.
Paw edema measurements
Change in hind paw width measured using digital calipers
(±0.1mm; VWR, Radnor, PA) was calculated as an average of the
left and right paw widths. Baseline paw widths for each mouse
were taken pre-treatment and subtracted from post-treatment paw
widths to calculate tissue edema as previously described2.
Myeloperoxidase measurements
Footpads were extracted from hind paws of mice euthanized
by CO2 inhalation, weighed, frozen at -80°C in 5.6μl/mg tissue
weight of 50mM K2HPO4 buffer (pH 6.0) (Sigma-Aldrich, St. Louis, MO) containing 0.05% hexadecyltrimethylammonium bromide
(HTAB) (Sigma-Aldrich, St. Louis, MO), thawed, homogenized in
5x the storage volume of HTAB buffer, sonicated with a 550 Sonic
Dismembrator (Fisher Scientific, Waltham, MA), freeze-thawed,
and centrifuged (AllegraX-15R; Beckman Coulter, Inc., Pasadena, CA) as previously described2,13. Absorbance was recorded
using a BioTek PowerWave XS plate reader (BioTek, Winooski,
VT) at 450nm after a 20-minute incubation in 50mM phosphate
buffer (pH 6.0) with 0.025% hydrogen peroxide (Sigma Aldrich,
St. Louis, MO) and 0.167mg/ml o-dianisidine-dihydrochloride
(Sigma Aldrich, St. Louis, MO) at room temperature in the dark.
Myeloperoxidase (MPO) levels were normalized to tissue weight
and presented as OD/g of wet tissue.
TNF-α measurements
For protein and gene expression studies, hind paws were excised
from mice euthanized by CO2 inhalation, flash-frozen in liquid nitrogen and stored at -80°C.
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Histology
Excised hind paws (from mice euthanized by CO2 inhalation) were
fixed in 10% buffered formalin (VWR, Radnor, PA) for 24 hours,
transferred to 70% ethanol (Sigma-Aldrich, St. Louis, MO), decalcified for 1–2 weeks in 15% EDTA, hydrated, and embedded
in paraffin. 4μm sagittal sections were stained with toluidine blue
(Tb) at pH 2.3 for 3 minutes (Sigma-Aldrich, St. Louis, MO) or
hematoxylin and eosin (H&E) (Sigma-Aldrich, St. Louis, MO)
for the detection of mast cells or neutrophils, respectively, at 400x
magnification with ≥3 biological replicates per treatment. Tbstained mast cells were counted in 10 fields/section and degranulation was scored based on the number of granules observed outside
the boundary of the cell: intact (0), mild (1–10), moderate (10–20),
and extensive (20+) as previously described2. The same investigator performed all counts and was blinded to treatment groups. Neutrophils were imaged between the heel and the toes on the plantar
side of the hind paw section using an Olympus CX21LED light
microscope and camera (Olympus Corporation of the Americas,
Center Valley, PA).
Statistical analysis
Data were processed using Microsoft Excel (Redmond, WA) and
graphed with PRISM 5.0 (GraphPad, San Diego, CA). All statistical analyses were performed using JMP 9.0 (SAS, Cary, NC).
All data are presented as the mean ±SEM. Data were analyzed using one-way ANOVA, and the Tukey-Kramer HSD post hoc test,
at each time point. Statistical significance was defined as p<0.05.
Thermal sensitivity and hind paw edema measurements included
15–18 mice per treatment group. Other analyses used 3–9 mice per
treatment group. All data represent 2–3 independent experiments.

Male ND4 Swiss mice bilaterally injected with 1500ng of c48/80 in
the hind paws showed hyperalgesic withdrawal responses ~10 seconds
sooner than their baseline withdrawal 30 minutes after treatment; these
responses were resolved by 2.5 hours (Figure 1A). Pre-treatment with
an intravenous injection of 200μg/kg TNF-α neutralizing antibody
30 minutes prior to c48/80 injection significantly abrogated these
responses at 30 minutes and 1.5 hours after intra-plantar treatment
with c48/80; pre-treated mice showed hyperalgesic withdrawal
A

10

∆ thermal latency (sec)

To measure cytokine gene expression, total RNA was extracted from
flash-frozen plantar tissue (Total RNA Mini Kit, Midwest Scientific,
St. Louis, MO), quantified with Nanodrop ND-1000 Spectrophotometer (Thermo Scientific, Wilmington, DE), and reverse-transcribed in
a 2720 Thermal Cycler (Life Technologies, Grand Island, NY) using
the Superscript III First-Strand Synthesis System (Life Technologies, Grand Island, NY) with 100ng of RNA per reaction. Relative
transcript abundance was determined by quantitative comparative
reverse transcriptase PCR (qRT-PCR)14 using TaqMan Gene Expression Assay Primer/Probe Sets and TaqMan MasterMix (Life Technologies, Grand Island, NY) in a Bio-Rad iCycler (Bio-Rad, Hercules, CA) using β-2-microglobulin (β2m; Mm00437762_m1, Life
Technologies, Grand Island, NY) and TNF-α (Mm00443260_g1,
Life Technologies, Grand Island, NY) primer sets. Fold expression
was normalized to β-2-microglobulin levels and calculated as previously described14,15.

Results
TNF-α neutralizing antibody blocks thermal hyperalgesia
and early tissue swelling induced by compound
48/80-provoked mast cell degranulation in the hind paw
tissue of ND4 mice
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For protein studies, flash-frozen paws were homogenized in Cell
Lysis Buffer (Cell Signaling Technology, Beverly, MA) supplemented with protease inhibitor (Cocktail Set IV; EMD Biosciences,
Billerica, MA) using a Tissue-Tearor (BioSpec; Model 985370).
Homogenates were incubated on ice for 20 minutes, centrifuged at
2000 rpm for 10 minutes at 4°C, and lysate supernatants stored at
-80°C. We quantified TNF-α cytokine levels by ELISA according
to the manufacturer’s instructions (eBioscience, San Diego, CA).
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Figure 1. Anti-TNF-α neutralizing antibody abrogates c48/80induced thermal hyperalgesia. Mice were pre-treated with 200μg/
kg anti-TNF-α neutralizing antibody or vehicle (200μ, i.v.) 30 minutes
before bilateral intra-plantar c48/80 or 0.9% saline injections (1.5μg/
paw; 10μl). The bars represent the mean change in thermal paw
withdrawal latency (A) and the change in paw width (B) from
baseline and error bars represent ± SEM. Anti-TNF-α administration
abrogated thermal hyperalgesia at 0.5 and 1.5h after c48/80 injection
(A) and reduced paw edema significantly at 0.5h (B). Significances
are compared to Sal/Sal (# = p<0.05; ## = p<0.001) and Sal/c48/80
(* = p<0.05; *** = p<0.001). n = 12 in Sal/Sal; n = 18 for Sal/c48/80;
n = 19 for anti-TNF/c48/80 treatment groups; data are pooled from
2 independent experiments.
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Figure 2. Pre-treatment with anti-TNF-α does not affect c48/80provoked mast cell degranulation. Mice were pre-treated with
200μg/kg anti-TNF-α neutralizing antibody or vehicle (200μl, i.v.)
30 minutes before bilateral intra-plantar c48/80 injection (1.5μg/
paw; 10μl). Mice were euthanized 2.5h after c48/80 administration;
their hind paws were harvested, preserved in 10% buffered formalin
and ethanol, and 4μm paraffin sections stained with toluidine blue
for mast cell visualization. Mast cells were counted at 400x and
their degranulation status was assessed as described previously2.
Bars represent mean percentages of mast cells examined that are
assigned to intact or mild, moderate and extensive degranulation
status respectively and the error bars represent ±SEM. n = 3 mice
per treatment group; data are representative of 2 experiments.

responses <5 seconds sooner than their baseline responses 30 minutes
after treatment (Figure 1A). Withdrawal responses of control and
anti-TNF-α treated groups were significantly different at 1.5 hours
after treatment and indistinguishable at 2.5 hours when the c48/80provoked hyperalgesic responses were resolved. Anti-TNF-α
pretreatment also significantly reduced hind paw edema compared
to mice without pre-treatment at 30 minutes but not at 1.5 and
2.5 hours (Figure 1B). Saline-treated control mice had no increase
in thermal sensitivity and showed no tissue swelling (Figure 1A–B).

To confirm that the antibody pre-treatment did not have an effect on
the extent of mast cell degranulation caused by c48/80 that would
have consequently affected mast cell-mediated hyperalgesia, we
evaluated the levels of degranulation in toluidine blue-stained 4μm
paraffin sections as previously described2 and confirmed that the
levels of mild, moderate and extensive degranulation were not altered in anti-TNF-α treated mice (Figure 2).
Taken together, pre-treatment with anti-TNF-α neutralizing antibody did not change the extent of local mast cell degranulation in
the mouse hind paw tissue but markedly reduced resulting thermal
sensitivity and tissue swelling provoked by injection of the basic
mast cell secretagogue c48/80.

Intra-plantar c48/80 administration does not induce
changes in TNF-α protein or mRNA levels in the hind paw
tissue of ND4 male mice
Mast cells contain pre-formed TNF-α in their granules16 that is released early upon degranulation16. We analyzed TNF-α protein and
mRNA levels in c48/80-treated and untreated hind paw tissue to
determine whether there was new synthesis of TNF-α immediately
following treatment with the basic mast cell secretagogue. We found
that neither protein nor mRNA levels of the cytokine detectably increased in the tissue within 3 hours following intra-plantar c48/80
injection (Figure 3A–B). Thus, it is most likely that the anti-TNF-α
neutralizing antibody treatment targets pre-formed, rather than newly synthesized, TNF-α molecules and this blockade contributes to
the resulting decrease in thermal sensitivity in the hind paw tissue.
TNF-α neutralizing antibody pre-treatment does not affect
early neutrophil recruitment in the tissue
Neutrophil influx into the affected tissue contributes to c48/80provoked hind paw thermal sensitivity2 and TNF-α is a known
neutrophil attractant3,17. We have previously shown that the

B

50

Fold expression
compared to β2M

TNF-α (pg/ml)

A

Overall, thermal sensitivity was reduced in a more sustained manner
compared to tissue edema.

40
30
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Sal/c48/80
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0.015
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0.005
Sal/Sal
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Figure 3. Intra-plantar c48/80 administration does not induce changes in TNF-α protein or mRNA levels in the hind paw tissue of ND4
male mice. Mice were pretreated with 200μg/kg anti-TNF-α neutralizing antibody or vehicle (200μl, i.v.) 30 minutes before bilateral intra-plantar
c48/80 injection (1.5μg/paw; 10μl). 2.5h after c48/80 treatment, their hind paws were excised and preserved for TNF-α protein quantification
by ELISA (A). Another set of mice was euthanized at 3h after c48/80 treatment; their footpads were excised for TNF-α mRNA abundance
quantification by qRT-PCR (B). Bars represent average pg/ml TNF-α protein (A) and fold-expression of TNF-α transcripts compared to β2m
(B) and the error bars represent ±SEM. n = 6 (Sal/Sal); 9 (Sal/c48/80) for ELISA assays and n = 3 mice per treatment group for qRT-PCR; data
are representative of 3 (ELISA) and 2 (qPCR) experiments.
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Figure 4. Pre-treatment with anti-TNF-α does not prevent c48/80-provoked neutrophil influx. Mice that received c48/80 intra-plantar
injections following anti-TNF-α pretreatment did not have significantly different levels of myeloperoxidase enzyme activity compared to
mice that received vehicle pretreatment (A). Hind paws were harvested from euthanized mice and assayed for MPO activity; bars represent
average MPO activity as OD/g wet tissue and error bars represent ±SEM (A). Mice were euthanized 2.5h after c48/80 administration, their
hind paws were harvested, preserved in 10% buffered formalin and ethanol, and 4μm paraffin sections stained with hematoxylin & eosin for
neutrophil visualization at 1000x. Similar to c48/80-treated mice (B), mice pre-treated with anti-TNF-α neutralizing antibody showed clear
evidence of neutrophil influx (indicated by black arrowheads) into the affected hind paw tissue (C). n = 3 mice per treatment group for MPO
assay; data are representative of 2 experiments.
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blockade of neutrophil influx can abrogate mast cell-dependent
thermal sensitivity in the mouse hind paw2. Therefore, we
investigated whether pre-treatment with the TNF-α neutralizing
antibody had an effect on neutrophil influx. We found that
levels of myeloperoxidase (an enzyme indicating the presence
of activated neutrophils) in the hind paw tissue of mice injected
bilaterally with 1500ng of c48/80 were not significantly reduced
with anti-TNF-α pre-treatment (Figure 4A). We further confirmed
this by examining the presence of neutrophils in 4μm paraffin
embedded hind paw tissue sections stained with H&E and found
that infiltrating neutrophils were present in the hind paws of mice
that received TNF-α neutralizing antibody (Figure 4B). Neutrophil
numbers in the hind paw tissue of mice following c48/80 injection
with and without anti-TNF-α pre-treatment were approximately
a total of ~150 neutrophils in 10 randomly chosen visualized
sections per paw (see Data File). Therefore, pre-treatment with
anti-TNF-α neutralizing antibody had little to no inhibitory effect
on the levels of tissue infiltrating neutrophils and myeloperoxidase
enzyme activity in the hind paw tissue of c48/80-treated mice.
Effect of TNF-α neutralizing antibody on thermal sensitivity
7 Data Files
http://dx.doi.org/10.6084/m9.figshare.773061

Discussion
Pain is a complex physiological and pathological phenomenon with
intricate underlying neuro-immune circuitry. Pain can be either
protective or maladaptive1,11 and in the former instance, serves as
an early warning system that prompts an organism to retreat from
noxious environmental stimuli.
We have previously shown that mast cells are required for enhanced
sensitivity to heat stimulus following c48/80 treatment in the hind paw
tissue of mice and blockade of neutrophil influx or histamine signaling
can abrogate these responses2. Here we show that pre-treatment with
TNF-α neutralizing antibody just prior to c48/80 administration
significantly reduces early thermal hyperalgesic responses. TNF-α
neutralizing antibody treatment does not affect mast cell degranulation;
levels of mild, modest and extensive degranulation following c48/80
treatment were similar to those previously described2. Mast cells
contain pre-formed TNF-α in their cytoplasmic granules and this
pro-inflammatory cytokine is one of the earliest mediators released
by these cells upon activation16. We looked for evidence of changes
in TNF-α protein and mRNA levels shortly after c48/80 treatment
and found none, suggesting that the pre-formed TNF released by
mast cells may be the main source of this cytokine in these experiments. As TNF-α is a known attractant of neutrophils17, we expected
TNF-α blockade to result in a reduction of infiltrating neutrophils.
We have previously shown that blockade of neutrophil influx can
abrogate c48/80-provoked thermal sensitivity2. However, we found
here that in the first 2.5 hours following c48/80 administration,
TNF-α neutralizing antibody pre-treatment had little to no effect
on recruitment of tissue neutrophils. The influx of neutrophils in the
presence of TNF-α neutralizing antibodies is supported by several
different kinds of evidence – myeloperoxidase activity in the tissue, visualization of neutrophils by H&E staining and neutrophil

counts in H&E stained tissue sections. However, given our relatively
small sample size for these assays, it is possible that a reduction in
neutrophil influx can be seen with larger numbers of mice. Nevertheless, our observations are in keeping with earlier studies that
show that mast cell mediators other than TNF-α can contribute to
the induction of neutrophil influx18. In these experiments, pain was
significantly abrogated as early as 30 minutes after c48/80 treatment
despite the presence of neutrophils.
TNF-α is one of the early inflammatory cytokines with a known
role in various nociceptive cascades6,7. Direct injection of TNF-α
in the hind paw tissue produces thermal and mechanical hyperalgesia in rodents6,19; anti-TNF-α antibody administration shortly before challenge reduces the hyperalgesic responses to carrageenan12
in mice and blockade of TNF-α induced neutrophil influx impairs
thermal carrageenan pain in rats3.
Our findings here add nuance to the prevailing model of mast cell
and neutrophil modulation of peripheral nociception with evidence
that TNF-α blockade can also abrogate very early thermal pain
responses without a proportional reduction in neutrophil influx. Hind
paw thermal pain provoked by c48/80 is markedly abrogated despite
the presence of infiltrating neutrophils in the tissue. In a model of
carrageenan-induced pain in rats, Cunha and colleagues have shown
that levels of TNF-α in the tissue are not affected by the absence of
infiltrating neutrophils i.e. these cells are not the primary sources of
TNF-α3 but rather the release of TNF-α and other cytokines such as
IL-1β in the tissue following an inflammatory insult serves to attract
infiltrating neutrophils that continue to fuel the nociceptive cascade3.
In preliminary experiments, we have found that pre-treatment with
antibodies against IL-1β reduces neutrophil influx into the tissue but
does not abrogate c48/80-provoked thermal pain at early time points
(data not shown). Therefore, the rapid anti-hyperalgesic effect that we
observe here may be due to the blockade of earlier effects of TNF-α
on nociceptor sensitization mediated by cyclooxygenase (COX)
and p38 mitogen-activated protein (MAP) kinase activation9,20 or
effects of TNF-α on nociceptor ion channels10,21. Our observations
here suggest that pre-formed TNF-α, e.g. from mast cell granules
in the skin mast cells, is the likely target of the TNF-α neutralizing
antibody that produces an early reduction of thermal sensitivity.
This is underscored by the documented proximity of nerves and
mast cells in the tissue8 and the known effects of mast cell-derived
TNF-α on nerve physiology - elongation of cutaneous nerves in
oxazolone contact hypersensitivity22, and susceptibility of sensory
neurons to agents such as capsaicin, in a model of tracheal vascular
hyper-permeability23. These known interactions further support the
idea that nociceptive neurons could be early downstream targets
of the first release of pre-formed TNF-α immediately after mast
cell degranulation. In this study, we show that early, protective,
nociceptive withdrawal responses to heat stimulus are compromised
by the blockade of TNF-α signaling. It has been documented that
individuals who use TNF-targeted biological therapeutics to
manage chronic autoimmune and inflammatory conditions can
experience a higher risk of bacterial and viral infections24. Our
findings here suggest that the use of TNF-α blockade therapies
may also compromise the protective, nociceptive responses of such
individuals leaving them more vulnerable to tissue damage from
injurious environmental stimuli.
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treatment with anti-TNF neutralizing antibodies did not completely abrogate neutrophil influx into
the c48/80-treated hind paw tissue.
Competing Interests: No competing interests were disclosed.

Reviewer Report 29 August 2013

https://doi.org/10.5256/f1000research.2114.r1562

Page 11 of 14

F1000Research 2013, 2:178 Last updated: 16 MAY 2019

© 2013 Piliponsky A. This is an open access peer review report distributed under the terms of the Creative Commons
Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original
work is properly cited.

Adrian Piliponsky
Seattle Children's Hospital, Seattle, USA
The study by Chatterjea D et al. is well-designed; its conclusions are balanced and justified based on the
results shown. I think that it could be relevant to know whether TNF-alpha injections can mimic the effects
of c48/80 injections in the model used: hyperalgesic withdrawal responses.
Figure 4a leads to the conclusion that neutrophil influx is not affected by treatment with anti-TNFalpha
antibodies and c48/80. Data is based on n=3 according to figure legend, though there is a trend for
neutrophil numbers to be reduced by treatment with anti-TNFalpha antibodies. I am wondering whether
the authors have considered increasing the number of mice for this experiment. If it is definitely not the
case that neutrophils numbers are reduced, it remains unexplained why there is a discrepancy with a
previous study, in which the authors demonstrated that neutrophils are an important component of the
hyperalgesic response induced by c48/80.
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Competing Interests: No competing interests were disclosed.

Reviewer Report 29 August 2013

https://doi.org/10.5256/f1000research.2114.r1561
© 2013 Drummond P. This is an open access peer review report distributed under the terms of the Creative Commons
Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original
work is properly cited.

Page 12 of 14

F1000Research 2013, 2:178 Last updated: 16 MAY 2019

Peter D. Drummond
School of Psychology and Exercise Science, Centre for Research on Chronic Pain and Inflammatory
Diseases, Murdoch University, Perth, WA, Australia
This paper makes a strong case for the early involvement of mast cell-derived TNF-alpha in thermal
hyperalgesia and oedema during inflammatory reactions. The only contentious issue is the suggestion
that TNF-alpha acts directly on nociceptors, rather than via the cascade of inflammatory mediators
triggered by TNF release. The references cited in support of this view either did not directly address this
point, or did not provide the intended support. For example, Zhang et al. (2011) (reference 9 in the paper)
proposed that TNF-alpha sensitizes meningeal nociceptors indirectly via local COX activity and the p38
MAPK signalling cascade, rather than by direct actions on nociceptors. Wang et al. (J Mol Neurosci
2007;32:207-216) reported that TNF receptors in the sciatic nerve were expressed primarily on Schwann
cells rather than neurons, leaving open the possibility that Schwann cells are involved in the inflammatory
cascade triggered by TNF-alpha.
One other minor point: I think this sentence in the first paragraph of the Results "Saline-treated control
mice had no increase in thermal sensitivity and showed no tissue swelling after c48/80 treatment" should
be "Saline-treated control mice had no increase in thermal sensitivity and showed no tissue swelling".
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